TickerFacts.

Idexx Laboratories Inc (IDXX): Total Assets

Annual figures by period end, from SEC filings.

$3.35B
As of 2025-12-31
$3.44B
As of 2026-06-30
+6.8%
3-year compound annual growth
+7.9%
5-year compound annual growth
+8.6%
10-year compound annual growth
2009-12-31: $808.53M2010-12-31: $897.14M2011-12-31: $1.03B2012-12-31: $1.10B2013-12-31: $1.23B2014-12-31: $1.38B2015-12-31: $1.47B2016-12-31: $1.53B2017-12-31: $1.71B2018-12-31: $1.54B2019-12-31: $1.83B2020-12-31: $2.29B2021-12-31: $2.44B2022-12-31: $2.75B2023-12-31: $3.26B2024-12-31: $3.29B2025-12-31: $3.35B$3.35B
2009-12-31 Total Assets (USD) 2025-12-31
Period endedTotal AssetsChange YoYSource filing
2025-12-31$3.35B+1.7%2026-02-20, Balance as of period end
2024-12-31$3.29B+1.0%2026-02-20, Balance as of period end
2023-12-31$3.26B+18.7%2025-02-21, Balance as of period end
2022-12-31$2.75B+12.7%2024-02-22, Balance as of period end
2021-12-31$2.44B+6.2%2023-02-16, Balance as of period end
2020-12-31$2.29B+25.2%2022-02-16, Balance as of period end
2019-12-31$1.83B+19.2%2021-02-12, Balance as of period end
2018-12-31$1.54B-10.3%2020-02-14, Balance as of period end
2017-12-31$1.71B+11.9%2019-02-15, Balance as of period end
2016-12-31$1.53B+3.8%2018-02-16, Balance as of period end
2015-12-31$1.47B+6.6%2017-02-17, Balance as of period end
2014-12-31$1.38B+12.5%2016-02-17, Balance as of period end
2013-12-31$1.23B+11.5%2015-02-17, Balance as of period end
2012-12-31$1.10B+7.1%2014-02-18, Balance as of period end
2011-12-31$1.03B+14.9%2013-02-19, Balance as of period end
2010-12-31$897.14M+11.0%2012-02-17, Balance as of period end
2009-12-31$808.53Mn/a2012-02-17, Balance as of period end

Total Assets at similar companies

Companies with the same SEC industry code (In Vitro & In Vivo Diagnostic Substances), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedTotal AssetsChange YoY
Idexx Laboratories Inc (IDXX)2025-12-31$3.35B+1.7%
QuidelOrtho Corp (QDEL)2025-12-28$5.77B-10.2%
Lantheus Holdings, Inc. (LNTH)2025-12-31$2.23B+12.5%
Neogen Corp (NEOG)2026-05-31$3.35B-2.8%
Myriad Genetics Inc (MYGN)2025-12-31$706.60M-31.2%
Intellia Therapeutics, Inc. (NTLA)2025-12-31$842.13M-29.3%
Alpha Teknova, Inc. (TKNO)2025-12-31$103.58M-12.8%
Immucell Corp (ICCC)2025-12-31$42.53M-5.7%
Aspira Women's Health Inc. (AWHL)2025-12-31$5.46M-0.6%

Compare IDXX, QDEL, LNTH, NEOG side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗